<DOC>
	<DOCNO>NCT00974701</DOCNO>
	<brief_summary>This study aim assess capability PillCam Platform use PillCam ESO 2 Capsule : - Determining whether 1 ) active bleed Upper gastrointestinal ( UGI ) tract , 2 ) identify anatomic location acute overt UGI bleeding , 3 ) discriminate variceal versus non-variceal source UGI bleeding .</brief_summary>
	<brief_title>A Pilot Feasibility Study Evaluate Capsule Endoscopy</brief_title>
	<detailed_description>Upper gastrointestinal hemorrhage ( UGIH ) prevalent , clinically significant , expensive healthcare problem worldwide . The incidence acute , overt UGIH estimate 50-150 case per 100,000 adult United States population year . Clinical Significance / Rationale EGD currently accept community standard diagnosis management UGIH . Diagnostic EGD person present acute UGIH allow ( 1 ) differentiate source bleeding ( variceal vs. non-variceal ) , ( 2 ) define anatomic location bleed site ( e.g. , esophagus , stomach , duodenum ) , ( 3 ) provide endoscopic diagnosis , ( 4 ) facilitate patient triage subsequent level care ( ICU , monitor bed , non-monitored bed , early / expedite hospital discharge ) . Capsule endoscopy small bowel clear FDA 2001 , within short time , gain acceptance provide state-of-the-art endoscopic imaging . Capsule endoscopy commonly use evaluation patient obscure gastrointestinal bleeding , include iron deficiency anemia , suspect know Crohn 's disease , malabsorption syndrome ( e.g. , Celiac disease ) , chronic abdominal pain . Capsule endoscopy technology also apply evaluation esophagus ( PillCam® ESO , Given Imaging , Ltd , Yoqneam , Israel ) colon ( PillCam® COLON ) . Recently , second generation esophageal capsule endoscope ( PillCam® ESO 2 , Given Imaging Ltd , Yoqneam , Israel ) clear United States Food Drug Administration June 2007 . While out dimension ( length diameter ) original PillCam ESO capsule , several significant improvement make internal component PillCam ESO 2 . Similar original PillCam ESO , system include sensor array data record device connect patient procedure . The recorded data download Given Imaging RAPID® workstation review capsule endoscopy video . However , publish detailed data evaluate feasibility utilize PillCam ESO 2 individual present acute , overt UGI bleeding . Moreover , data compare PillCam ESO 2 EGD evaluation patient population . Therefore , proof-of-concept pilot study , evaluate feasibility safety use PillCam ESO 2 individual present acute , overt UGI bleeding .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<criteria>age ≥ 18 year history acute , overt UGI hemorrhage , define hematemesis ( fresh blood coffee ground ) and/or melena within 48 hour prior patient presentation dysphagia odynophagia know swallow disorder history Zencker 's diverticulum suspect bowel obstruction bowel perforation time presentation UGI hemorrhage hemodynamic shock require urgent endoscopy history prior bowel obstruction history Crohn 's disease history UGI tract surgery ( e.g. , Billroth I , Billroth II , esophagectomy , gastrectomy , bariatric procedure ) presence electromedical device ( pacemaker internal cardiac defibrillator ) alter mental status ( e.g. , hepatic encephalopathy ) time presentation would limit patient ability swallow capsule pregnancy know allergy conscious sedation medication know allergy erythromycin inability provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>symptom acute overt upper gastrointestinal hemorrhage</keyword>
</DOC>